FdaApplication
BLA 761127
Identifiers
- fda_app_no: BLA761127
Properties
| Property | Value |
|---|---|
| applicant_name | Revance Therapeutics, Inc. |
| application_type | BLA |
| approval_date | 2022-09-07 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DAXXIFY | DAXIBOTULINUMTOXINA-LANM | 50UNITS | For Injection |
| DAXXIFY | — | 100UNITS | For Injection |
2 products